Nature Communications (Aug 2023)

An integrated organoid omics map extends modeling potential of kidney disease

  • Moritz Lassé,
  • Jamal El Saghir,
  • Celine C. Berthier,
  • Sean Eddy,
  • Matthew Fischer,
  • Sandra D. Laufer,
  • Dominik Kylies,
  • Arvid Hutzfeldt,
  • Léna Lydie Bonin,
  • Bernhard Dumoulin,
  • Rajasree Menon,
  • Virginia Vega-Warner,
  • Felix Eichinger,
  • Fadhl Alakwaa,
  • Damian Fermin,
  • Anja M. Billing,
  • Akihiro Minakawa,
  • Phillip J. McCown,
  • Michael P. Rose,
  • Bradley Godfrey,
  • Elisabeth Meister,
  • Thorsten Wiech,
  • Mercedes Noriega,
  • Maria Chrysopoulou,
  • Paul Brandts,
  • Wenjun Ju,
  • Linda Reinhard,
  • Elion Hoxha,
  • Florian Grahammer,
  • Maja T. Lindenmeyer,
  • Tobias B. Huber,
  • Hartmut Schlüter,
  • Steffen Thiel,
  • Laura H. Mariani,
  • Victor G. Puelles,
  • Fabian Braun,
  • Matthias Kretzler,
  • Fatih Demir,
  • Jennifer L. Harder,
  • Markus M. Rinschen

DOI
https://doi.org/10.1038/s41467-023-39740-7
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 21

Abstract

Read online

Abstract Kidney organoids are a promising model to study kidney disease, but their use is constrained by limited knowledge of their functional protein expression profile. Here, we define the organoid proteome and transcriptome trajectories over culture duration and upon exposure to TNFα, a cytokine stressor. Older organoids increase deposition of extracellular matrix but decrease expression of glomerular proteins. Single cell transcriptome integration reveals that most proteome changes localize to podocytes, tubular and stromal cells. TNFα treatment of organoids results in 322 differentially expressed proteins, including cytokines and complement components. Transcript expression of these 322 proteins is significantly higher in individuals with poorer clinical outcomes in proteinuric kidney disease. Key TNFα-associated protein (C3 and VCAM1) expression is increased in both human tubular and organoid kidney cell populations, highlighting the potential for organoids to advance biomarker development. By integrating kidney organoid omic layers, incorporating a disease-relevant cytokine stressor and comparing with human data, we provide crucial evidence for the functional relevance of the kidney organoid model to human kidney disease.